Highlights
NASDAQ: MCRB       Seres Theraptc
Last Price Today's Change   Day's Range   Trading Volume
3.66   -0.21 (5.43%)  3.60 - 4.06  222,403

Overview

 
Avg Volume (4 weeks):187,850
4 Weeks Range:3.15 - 4.09
4 Weeks Price Volatility (%):
54.26%
52 Weeks Range:2.02 - 8.82
52 Weeks Price Volatility (%):
24.12%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109, the company’s product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-155.

  Be the first to like this.
 


 

2588  3102  365  2924 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.644-0.056 
 AMD 39.88+1.32 
 ACB 2.27-0.46 
 I 8.03-5.38 
 AABA 19.630.00 
 GE 11.43-0.09 
 UBER 26.76-0.03 
 AMRN 22.60-1.42 
 F 8.94-0.01 
 SNAP 14.69+0.75 
Partners & Brokers